e-learning
resources
Conferences
Sleep and Breathing Conferences 2015-2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases?
Walter McNicholas (Dublin, Ireland)
Source:
Sleep and Breathing Conference 2017
Number:
9
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Walter McNicholas (Dublin, Ireland). Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases?. Sleep and Breathing Conference 2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Related content which might interest you:
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001
Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005
Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016
Year: 2017
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002
Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Source: Eur Respir J 2007; 29: 156-178
Year: 2007
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Physical activity: the key to cardiometabolic risk reduction in obstructive sleep apnoea
Source: Eur Respir J, 52 (4) 1801775; 10.1183/13993003.01775-2018
Year: 2018
Is there a gender difference in cardiovascular mortality in obstructive sleep apnoea?
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006
Association between childhood obstructive sleep apnoea and risk of early osteoporosis.
Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill
Year: 2019
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept